Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Mar;2(2):236–237. doi: 10.1128/cdli.2.2.236-237.1995

beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans.

E M Piwowar 1, S B Tugume 1, R M Grant 1, T Lutalo 1, K Pattishall 1, E Katongole-Mbidde 1
PMCID: PMC170135  PMID: 7697536

Abstract

Mean serum beta-2 microglobulin levels among healthy human immunodeficiency virus-seronegative and asymptomatic and symptomatic human immunodeficiency virus-seropositive Ugandans were found to be 2.35, 3.75, and 5.06 mg/liter, respectively (P < 0.001). The upper limit of the normal range (3.5 mg/liter) is higher in this African population than that reported elsewhere.

Full Text

The Full Text of this article is available as a PDF (147.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. E., Lang W., Shiboski S., Royce R., Jewell N., Winkelstein W., Jr Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Arch Intern Med. 1990 Jan;150(1):73–77. [PubMed] [Google Scholar]
  2. Burkes R. L., Sherrod A. E., Stewart M. L., Gill P. S., Aguilar S., Taylor C. R., Krailo M. D., Levine A. M. Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy. Cancer. 1986 Jun 1;57(11):2190–2192. doi: 10.1002/1097-0142(19860601)57:11<2190::aid-cncr2820571118>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  3. Calabrese L. H., Proffitt M. R., Gupta M. K., Easley K. A., Walker J. R., Rehm S. J., Valenzuela R., Clough J. D. Serum beta 2-microglobulin and interferon in homosexual males: relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III). AIDS Res. 1984;1(6):423–438. doi: 10.1089/aid.1.1983.1.423. [DOI] [PubMed] [Google Scholar]
  4. Gorter R. W., Vranizan K. M., Osmond D. H., Moss A. R. Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS. 1992 Nov;6(11):1341–1347. doi: 10.1097/00002030-199211000-00017. [DOI] [PubMed] [Google Scholar]
  5. Rathbun R. C. Surrogate markers for assessing treatment response in HIV disease. Ann Pharmacother. 1993 Apr;27(4):450–455. doi: 10.1177/106002809302700412. [DOI] [PubMed] [Google Scholar]
  6. Witt P. L., Spear G. T., Lindstrom M. J., Kessler H. A., Borden E. C., Phair J., Landay A. L. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS. 1991 Mar;5(3):289–293. doi: 10.1097/00002030-199103000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES